Evidence map›Paper›PMID 33982246›Full record

ArticleStem cell reviews and reports2021

SOX9-induced Generation of Functional Astrocytes Supporting Neuronal Maturation in an All-human System.

Katrien Neyrinck, Johanna Van Den Daele, Tim Vervliet, Jonathan De Smedt, Keimpe Wierda, Melissa Nijs, Tom Vanbokhoven, Astrid D'hondt, Mélanie Planque, Sarah-Maria Fendt and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Stem cell reviews and reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Parkinson's Disease Patient-Specific Striatum Organoids Show Hallmarks of Increased Inflammation.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Altered Lipid Homeostasis in Mutant FUSMolecular neurobiology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Katrien Neyrinck *Stem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium. katrien.neyrinck@kuleuven.be.ORCID 0000-0001-5667-9663
Johanna Van Den Daele *Stem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium. johanna.vandendaele@kuleuven.be.
Tim VervlietLaboratory of Molecular and Cellular Signalling, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Jonathan De SmedtStem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium.
Keimpe WierdaElectrophysiology Expert Unit, VIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium.
Melissa NijsStem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium.
Tom VanbokhovenStem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium.
Astrid D'hondtStem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium.
Mélanie PlanqueLaboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncoloy, KU Leuven and Leuven Cancer Institute (LKI), Leuven, 3000, Belgium.
Sarah-Maria FendtLaboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncoloy, KU Leuven and Leuven Cancer Institute (LKI), Leuven, 3000, Belgium.
Pei-Yu ShihDivision of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.
Frederik SeibtDivision of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.
Juan Pita AlmenarDivision of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.
Mohamed KreirDivision of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.
Devesh KumarDivision of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.
Vania BroccoliDivision of Neuroscience, IRCCS, San Raffaele Scientific Hospital, 20132, Milan, Italy.
Geert BultynckLaboratory of Molecular and Cellular Signalling, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Andreas EbnethDivision of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.
Alfredo Cabrera-SocorroDivision of Janssen Pharmaceutica, Janssen Research & Development, Beerse, 2340, Belgium.
Catherine VerfaillieStem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, 3000, Belgium. catherine.verfaillie@kuleuven.be.
Janssen (Belgium) · BEKU Leuven · BERega Institute for Medical Research · BEVIB-KU Leuven Center for Cancer Biology · BEVIB-KU Leuven Center for Brain & Disease Research · BEVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astrocytes, the main supportive cell type of the brain, show functional impairments upon ageing and in a broad spectrum of neurological disorders. Limited access to human astroglia for pre-clinical studies has been a major bottleneck delaying our understanding of their role in brain health and disease. We demonstrate here that functionally mature human astrocytes can be generated by SOX9 overexpression for 6 days in pluripotent stem cell (PSC)-derived neural progenitor cells. Inducible (i)SOX9-astrocytes display functional properties comparable to primary human astrocytes comprising glutamate uptake, induced calcium responses and cytokine/growth factor secretion. Importantly, electrophysiological properties of iNGN2-neurons co-cultured with iSOX9-astrocytes are indistinguishable from gold-standard murine primary cultures. The high yield, fast timing and the possibility to cryopreserve iSOX9-astrocytes without losing functional properties makes them suitable for scaled-up production for high-throughput analyses. Our findings represent a step forward to an all-human iPSC-derived neural model for drug development in neuroscience and towards the reduction of animal use in biomedical research.

Indexed as

AstrocytesNeural Stem CellsAnimalsHumansInduced Pluripotent Stem CellsMiceNeurogenesisNeuronsSOX9 Transcription FactorSOX9 protein, humanSOX9 Transcription FactorAll-human co-culture systemAstrocytesDifferentiation protocolGenome engineeringPluripotent stem cells

Identifiers

PMID33982246
PMCPMC8553725
OpenAlexW3160191010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.